A. Ulvik et al., Smoking, folate and methylenetetrahydrofolate reductase status as interactive determinants of adenomatous and hyperplastic polyps of colorectum, AM J MED G, 101(3), 2001, pp. 246-254
Most studies demonstrate increased risk of colorectal cancer (CRC) and aden
omas in folate-deficient subjects or that high folate intake may afford som
e protection. Smoking increases such risk in some but not all studies. We i
nvestigated whether smoking, folate status and methylenetetrahydrofolate re
ductase (MTHFR) genotype predict the risk of adenomatous and hyperplastic p
olyps of colorectum. By colonoscopy, the type, number, size and extent of d
ysplasia of colorectal polyps were assessed in 443 subjects aged 63-72 year
s. We also determined RBC folate and the C667T polymorphism of the methylen
etetrahydrofolate reductase (MTHFR) gene. Smoking, folate status and the C6
77T MTHFR polymorphism were strong, interactive determinants of highrisk ad
enomas (HRAs, defined as adenomas greater than or equal to 10 mm in diamete
r, adenomas with villous components or with severe dysplasia). The risk was
particularly high in smokers with low folate and the CT/TT genotype (risk
category T) and in smokers with high folate and the CC genotype (risk categ
ory C). With non-smokers with low folate and the CC genotype as reference,
the odds ratios (OR, 95% CI) were 8.7 (2.5-29.7) in category T and 9.9 (2.6
-38.4) in category C. Notably, this risk pattern was also observed for hype
rplastic polyps. In conclusion, in smokers, high folate status may confer i
ncreased or decreased risk for HRAs, depending on the MTHFR genotype. These
data demonstrate the strong gene-nutrition interaction involving the C677T
MTHFR polymorphism. (C) 2001 Wiley-Liss, Inc.